12-48769027-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_015270.5(ADCY6):c.3291C>T(p.Ile1097=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00244 in 1,612,836 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 48 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 41 hom. )
Consequence
ADCY6
NM_015270.5 synonymous
NM_015270.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.301
Genes affected
ADCY6 (HGNC:237): (adenylate cyclase 6) This gene encodes a member of the adenylyl cyclase family of proteins, which are required for the synthesis of cyclic AMP. All members of this family have an intracellular N-terminus, a tandem repeat of six transmembrane domains separated by a cytoplasmic loop, and a C-terminal cytoplasmic domain. The two cytoplasmic regions bind ATP and form the catalytic core of the protein. Adenylyl cyclases are important effectors of transmembrane signaling pathways and are regulated by the activity of G protein coupled receptor signaling. This protein belongs to a small subclass of adenylyl cyclase proteins that are functionally related and are inhibited by protein kinase A, calcium ions and nitric oxide. A mutation in this gene is associated with arthrogryposis multiplex congenita. [provided by RefSeq, May 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 12-48769027-G-A is Benign according to our data. Variant chr12-48769027-G-A is described in ClinVar as [Benign]. Clinvar id is 788579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.301 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0134 (2035/152202) while in subpopulation AFR AF= 0.0459 (1905/41508). AF 95% confidence interval is 0.0442. There are 48 homozygotes in gnomad4. There are 926 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 48 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADCY6 | NM_015270.5 | c.3291C>T | p.Ile1097= | synonymous_variant | 21/22 | ENST00000357869.8 | NP_056085.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADCY6 | ENST00000357869.8 | c.3291C>T | p.Ile1097= | synonymous_variant | 21/22 | 2 | NM_015270.5 | ENSP00000350536 | P1 | |
ADCY6 | ENST00000307885.4 | c.3291C>T | p.Ile1097= | synonymous_variant | 20/21 | 1 | ENSP00000311405 | P1 | ||
ADCY6 | ENST00000550422.5 | c.3132C>T | p.Ile1044= | synonymous_variant | 20/21 | 2 | ENSP00000446730 | |||
ADCY6 | ENST00000547260.5 | n.2145C>T | non_coding_transcript_exon_variant | 6/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0134 AC: 2033AN: 152084Hom.: 48 Cov.: 32
GnomAD3 genomes
AF:
AC:
2033
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00362 AC: 906AN: 250180Hom.: 23 AF XY: 0.00248 AC XY: 336AN XY: 135362
GnomAD3 exomes
AF:
AC:
906
AN:
250180
Hom.:
AF XY:
AC XY:
336
AN XY:
135362
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00130 AC: 1906AN: 1460634Hom.: 41 Cov.: 32 AF XY: 0.00111 AC XY: 808AN XY: 726598
GnomAD4 exome
AF:
AC:
1906
AN:
1460634
Hom.:
Cov.:
32
AF XY:
AC XY:
808
AN XY:
726598
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0134 AC: 2035AN: 152202Hom.: 48 Cov.: 32 AF XY: 0.0124 AC XY: 926AN XY: 74410
GnomAD4 genome
AF:
AC:
2035
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
926
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at